Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Social vulnerability and survival among patients with high-grade glioma treated at a tertiary cancer center.
Journal: Journal of neuro-oncology
Published: May 30, 2026
Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology.
Journal: Journal of neuro-oncology
Published: May 23, 2026
Clinical and Molecular Features of BAP1-Mutated Meningiomas: Case Series.
Journal: Molecular carcinogenesis
Published: February 13, 2026
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2025
Application of 200 kHz Tumor Treating Fields (TTFields) in Patients With Infratentorial High-Grade Glioma: Case Series.
Journal: Brain tumor research and treatment
Published: October 13, 2025
Single center experience of IDH inhibitors in recurrent high-grade gliomas.
Journal: Journal of neuro-oncology
Published: June 02, 2025
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapy.
Journal: Journal of neuro-oncology
Published: May 05, 2025
Differential diagnosis in immune checkpoint inhibitors neurotoxicity.
Journal: Journal of neurology
Published: November 26, 2024
MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas.
Journal: Cancers
Published: August 23, 2024
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas.
Journal: Neuro-oncology
Published: August 10, 2024
Last Updated: 09/26/2026